SummaryThe CDC advisory committee has ended the long-standing recommendation for universal hepatitis B vaccination at birth, advising discussions for babies of mothers who test negative. Experts warn that hidden infections, infant vulnerability and past success of the birth-dose strategy mean risk remains. Many countries still recommend universal newborn vaccination.